Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 12/2014

01.12.2014 | Glaucoma

Results of long-term monitoring of normal-tension glaucoma patients receiving medical therapy: results of an 18-year follow-up

verfasst von: Shinya Komori, Kyoko Ishida, Tetsuya Yamamoto

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 12/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To conduct a ≥15-year follow-up assessment of the visual field (VF) in normal-tension glaucoma (NTG) patients receiving medical therapy and to identify risk factors for VF progression.

Design

A retrospective clinical study.

Methods

Medical records of 78 eyes of 78 NTG patients monitored for ≥15 years were reviewed. VF progression was defined by a mean deviation (MD) deteriorated twice by 3.00 dB from baseline (MD criterion) and an annual decrease in the MD slope exceeding −0.5 dB/year (MD slope criterion). Logistic regression analysis was employed to identify risk factors for VF progression.

Results

The mean follow-up period was 18.3 years. The average intraocular pressure (IOP) before treatment was 15.1 ±1.9 mmHg and the average treated IOP was 13.5 ±1.5 mmHg with 2.0 medications. Forty-two eyes (53.8%) showed VF progression using the MD criterion and 15 eyes (19.2%) showed a negative MD slope less than −0.5 dB/year. Disc hemorrhage (DH) was observed in 30 eyes (38.5%). The mean VF progression rate was −0.38 ±0.30 dB/year in the DH group and −0.24 ±0.28 dB/year in the non-DH group (P = 0.012). Multiple logistic regression analysis identified DH [relative risk (RR) 4.28; P = 0.028] as a risk factor for VF progression using the MD criterion. DH (RR 8.77; P = 0.007) and IOP fluctuation during follow-up (RR 5.03; P = 0.048) were detected as risk factors using the MD slope criterion.

Conclusions

DH and IOP fluctuation were associated with VF progression in NTG during long-term therapy.
Literatur
1.
Zurück zum Zitat Collaborative Normal-Tension Glaucoma Study Group (1998) Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 126:487–497CrossRef Collaborative Normal-Tension Glaucoma Study Group (1998) Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 126:487–497CrossRef
2.
Zurück zum Zitat Collaborative Normal-Tension Glaucoma Study Group (1998) The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 126:498–505CrossRef Collaborative Normal-Tension Glaucoma Study Group (1998) The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 126:498–505CrossRef
3.
Zurück zum Zitat Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z; EMGT Group (2007) Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 114:1965–1972CrossRef Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z; EMGT Group (2007) Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 114:1965–1972CrossRef
4.
Zurück zum Zitat Ishida K, Yamamoto T, Kitazawa Y (1998) Clinical factors associated with progression of normal-tension glaucoma. J Glaucoma 7:372–377PubMedCrossRef Ishida K, Yamamoto T, Kitazawa Y (1998) Clinical factors associated with progression of normal-tension glaucoma. J Glaucoma 7:372–377PubMedCrossRef
5.
Zurück zum Zitat Ishida K, Yamamoto T, Sugiyama K, Kitazawa Y (2000) Disk hemorrhage is a significantly negative prognostic factor in normal-tension glaucoma. Am J Ophthalmol 129:707–714PubMedCrossRef Ishida K, Yamamoto T, Sugiyama K, Kitazawa Y (2000) Disk hemorrhage is a significantly negative prognostic factor in normal-tension glaucoma. Am J Ophthalmol 129:707–714PubMedCrossRef
6.
Zurück zum Zitat Ma KT, Kim CY, Seong GJ et al (2011) Intraocular pressure reduction in normal-tension glaucoma patients in South Korea. Int Ophthalmol 31:355–361PubMedCrossRef Ma KT, Kim CY, Seong GJ et al (2011) Intraocular pressure reduction in normal-tension glaucoma patients in South Korea. Int Ophthalmol 31:355–361PubMedCrossRef
7.
Zurück zum Zitat Nakagami T, Yamazaki Y, Hayamizu F (2006) Prognostic factors for progression of visual field damage in patients with normal-tension glaucoma. Jpn J Ophthalmol 50:38–43PubMedCrossRef Nakagami T, Yamazaki Y, Hayamizu F (2006) Prognostic factors for progression of visual field damage in patients with normal-tension glaucoma. Jpn J Ophthalmol 50:38–43PubMedCrossRef
8.
Zurück zum Zitat Kim M, Kim DM, Park KH, Kim TW, Jeoung JW, Kim SH (2013) Intraocular pressure reduction with topical medications and progression of normal-tension glaucoma: a 12-year mean follow-up study. Acta Ophthalmol. doi:10.1111/aos.12082 PubMedCentral Kim M, Kim DM, Park KH, Kim TW, Jeoung JW, Kim SH (2013) Intraocular pressure reduction with topical medications and progression of normal-tension glaucoma: a 12-year mean follow-up study. Acta Ophthalmol. doi:10.​1111/​aos.​12082 PubMedCentral
9.
Zurück zum Zitat Drance S, Anderson DR, Schulzer M, for the Collaborative Normal-Tension Glaucoma Study Group (2001) Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol 131:699–708CrossRef Drance S, Anderson DR, Schulzer M, for the Collaborative Normal-Tension Glaucoma Study Group (2001) Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol 131:699–708CrossRef
10.
Zurück zum Zitat Hsieh JW, Lan YW, Wang IJ, Sun FJ (2010) Clinical characteristics and prognostic significance of disc hemorrhage in open-angle and angle-closure glaucoma. J Glaucoma 19:483–487PubMedCrossRef Hsieh JW, Lan YW, Wang IJ, Sun FJ (2010) Clinical characteristics and prognostic significance of disc hemorrhage in open-angle and angle-closure glaucoma. J Glaucoma 19:483–487PubMedCrossRef
11.
Zurück zum Zitat Nitta K, Sugiyama K, Higashide T, Ohkubo S, Tanahashi T, Kitazawa Y (2011) Does the enlargement of retinal nerve fiber layer defects relate to disc hemorrhage or progressive visual field loss in normal-tension glaucoma? J Glaucoma 20:189–195PubMedCrossRef Nitta K, Sugiyama K, Higashide T, Ohkubo S, Tanahashi T, Kitazawa Y (2011) Does the enlargement of retinal nerve fiber layer defects relate to disc hemorrhage or progressive visual field loss in normal-tension glaucoma? J Glaucoma 20:189–195PubMedCrossRef
12.
Zurück zum Zitat Araie M, Shirato S, Yamazaki Y, Matsumoto C, Kitazawa Y, Ohashi Y; Nipradilol‐Timolol Study Group (2012) Risk factors for progression of normal-tension glaucoma under β-blocker monotherapy. Acta Ophthalmol 90:337–343CrossRef Araie M, Shirato S, Yamazaki Y, Matsumoto C, Kitazawa Y, Ohashi Y; Nipradilol‐Timolol Study Group (2012) Risk factors for progression of normal-tension glaucoma under β-blocker monotherapy. Acta Ophthalmol 90:337–343CrossRef
13.
Zurück zum Zitat Daugeliene L, Yamamoto T, Kitazawa Y (1999) Risk factors for visual field damage progression in normal-tension glaucoma eyes. Graefes Arch Clin Exp Ophthalmol 237:105–108PubMedCrossRef Daugeliene L, Yamamoto T, Kitazawa Y (1999) Risk factors for visual field damage progression in normal-tension glaucoma eyes. Graefes Arch Clin Exp Ophthalmol 237:105–108PubMedCrossRef
14.
Zurück zum Zitat Ernest PJ, Schouten JS, Beckers HJ, Hendrikse F, Prins MH, Webers CA (2013) An evidence-based review of prognostic factors for glaucomatous visual field progression. Ophthalmology 120:512–519PubMedCrossRef Ernest PJ, Schouten JS, Beckers HJ, Hendrikse F, Prins MH, Webers CA (2013) An evidence-based review of prognostic factors for glaucomatous visual field progression. Ophthalmology 120:512–519PubMedCrossRef
15.
Zurück zum Zitat Sakata R, Aihara M, Murata H et al (2013) Contributing factors for progression of visual field loss in normal-tension glaucoma patients with medical treatment. J Glaucoma 22:250–254PubMedCrossRef Sakata R, Aihara M, Murata H et al (2013) Contributing factors for progression of visual field loss in normal-tension glaucoma patients with medical treatment. J Glaucoma 22:250–254PubMedCrossRef
16.
Zurück zum Zitat De Moraes CG, Liebmann JM, Greenfield DS, Gardiner SK, Ritch R, Krupin T on behalf of the Low-pressure Glaucoma Treatment Study Group (2012) Risk factors for visual field progression in the low-pressure glaucoma treatment study. Am J Ophthalmol 154:702–711CrossRef De Moraes CG, Liebmann JM, Greenfield DS, Gardiner SK, Ritch R, Krupin T on behalf of the Low-pressure Glaucoma Treatment Study Group (2012) Risk factors for visual field progression in the low-pressure glaucoma treatment study. Am J Ophthalmol 154:702–711CrossRef
17.
Zurück zum Zitat Sung KR, Lee S, Park SB et al (2009) Twenty-four hour ocular perfusion pressure fluctuation and risk of normal-tension glaucoma progression. Invest Ophthalmol Vis Sci 50:5266–5274PubMedCrossRef Sung KR, Lee S, Park SB et al (2009) Twenty-four hour ocular perfusion pressure fluctuation and risk of normal-tension glaucoma progression. Invest Ophthalmol Vis Sci 50:5266–5274PubMedCrossRef
18.
Zurück zum Zitat Heijl A, Bengtsson B, Hyman L, Leske MC for the Early Manifest Glaucoma Trial Group (2009) Natural history of open-angle glaucoma. Ophthalmology 116:2271–2276CrossRef Heijl A, Bengtsson B, Hyman L, Leske MC for the Early Manifest Glaucoma Trial Group (2009) Natural history of open-angle glaucoma. Ophthalmology 116:2271–2276CrossRef
19.
Zurück zum Zitat Anderson DR, Drance SM, Schulzer M; Collaborative Normal-Tension Glaucoma Study Group (2001) Natural history of normal-tension glaucoma. Ophthalmology 108:247–253CrossRef Anderson DR, Drance SM, Schulzer M; Collaborative Normal-Tension Glaucoma Study Group (2001) Natural history of normal-tension glaucoma. Ophthalmology 108:247–253CrossRef
20.
Zurück zum Zitat Ahrlich KG, De Moraes CG, Teng CC et al (2010) Visual field progression differences between normal-tension and exfoliative high-tension glaucoma. Invest Ophthalmol Vis Sci 51:1458–1463PubMedCrossRef Ahrlich KG, De Moraes CG, Teng CC et al (2010) Visual field progression differences between normal-tension and exfoliative high-tension glaucoma. Invest Ophthalmol Vis Sci 51:1458–1463PubMedCrossRef
21.
Zurück zum Zitat Broman AT, Quigley HA, West SK et al (2008) Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data. Invest Ophthalmol Vis Sci 49:66–76PubMedCentralPubMedCrossRef Broman AT, Quigley HA, West SK et al (2008) Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data. Invest Ophthalmol Vis Sci 49:66–76PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Lee J, Sohn SW, Kee C (2013) Effect of Ginkgo biloba extract on visual field progression in normal tension glaucoma. J Glaucoma 22:780–784PubMedCrossRef Lee J, Sohn SW, Kee C (2013) Effect of Ginkgo biloba extract on visual field progression in normal tension glaucoma. J Glaucoma 22:780–784PubMedCrossRef
23.
Zurück zum Zitat Hong S, Seong GJ, Hong YJ (2007) Long-term intraocular pressure fluctuation and progressive visual field deterioration in patients with glaucoma and low intraocular pressures after a triple procedure. Arch Ophthalmol 125:1010–1013PubMedCrossRef Hong S, Seong GJ, Hong YJ (2007) Long-term intraocular pressure fluctuation and progressive visual field deterioration in patients with glaucoma and low intraocular pressures after a triple procedure. Arch Ophthalmol 125:1010–1013PubMedCrossRef
24.
Zurück zum Zitat Caprioli J, Coleman AL (2008) Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study. Ophthalmology 115:1123–1129PubMedCrossRef Caprioli J, Coleman AL (2008) Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study. Ophthalmology 115:1123–1129PubMedCrossRef
25.
Zurück zum Zitat Medeiros FA, Weinreb RN, Zangwell LM et al (2008) Long-term intraocular pressure fluctuations and risk of conversion from ocular hypertension to glaucoma. Ophthalmology 115:934–940PubMedCentralPubMedCrossRef Medeiros FA, Weinreb RN, Zangwell LM et al (2008) Long-term intraocular pressure fluctuations and risk of conversion from ocular hypertension to glaucoma. Ophthalmology 115:934–940PubMedCentralPubMedCrossRef
26.
Zurück zum Zitat Healey PR, Mitchell P, Smith W, Wang JJ (1998) Optic disc hemorrhages in a population with and without signs of glaucoma. Ophthalmology 105:216–223PubMedCrossRef Healey PR, Mitchell P, Smith W, Wang JJ (1998) Optic disc hemorrhages in a population with and without signs of glaucoma. Ophthalmology 105:216–223PubMedCrossRef
27.
Zurück zum Zitat Tomita G, Araie M, Kitazawa Y, Tsukahara S (2004) A three-year prospective, randomized and open comparison between latanoprost and timolol in Japanese normal-tension glaucoma patients. Eye 18:984–989PubMedCrossRef Tomita G, Araie M, Kitazawa Y, Tsukahara S (2004) A three-year prospective, randomized and open comparison between latanoprost and timolol in Japanese normal-tension glaucoma patients. Eye 18:984–989PubMedCrossRef
28.
Zurück zum Zitat Araie M, Shirato S, Yamazaki Y, Kitazawa Y, Ohashi Y; Nipradilol-Timolol Study Group (2010) Visual field loss in patients with normal-tension glaucoma under topical nipradilol or timolol: subgroup and subfield analyses of the nipradilol-timolol study. Jpn J Ophthalmol 54:278–285CrossRef Araie M, Shirato S, Yamazaki Y, Kitazawa Y, Ohashi Y; Nipradilol-Timolol Study Group (2010) Visual field loss in patients with normal-tension glaucoma under topical nipradilol or timolol: subgroup and subfield analyses of the nipradilol-timolol study. Jpn J Ophthalmol 54:278–285CrossRef
29.
Zurück zum Zitat Budenz DL, Anderson DR, Feuer WJ, Ocular Hypertension Treatment StudyGroup et al (2006) Detection and prognostic significance of optic disc hemorrhages during the Ocular Hypertension Treatment Study. Ophthalmology 113:2137–2143PubMedCentralPubMedCrossRef Budenz DL, Anderson DR, Feuer WJ, Ocular Hypertension Treatment StudyGroup et al (2006) Detection and prognostic significance of optic disc hemorrhages during the Ocular Hypertension Treatment Study. Ophthalmology 113:2137–2143PubMedCentralPubMedCrossRef
30.
Zurück zum Zitat Kim YD, Han SB, Park KH et al (2010) Risk factors associated with optic disc haemorrhage in patients with normal tension glaucoma. Eye 24:567–572PubMedCrossRef Kim YD, Han SB, Park KH et al (2010) Risk factors associated with optic disc haemorrhage in patients with normal tension glaucoma. Eye 24:567–572PubMedCrossRef
32.
Zurück zum Zitat Soares AS, Artes PH, Andreou P, Leblanc RP, Chauhan BC, Nicolela MT (2004) Factors associated with optic disc hemorrhages in glaucoma. Ophthalmology 111:1653–1657PubMedCrossRef Soares AS, Artes PH, Andreou P, Leblanc RP, Chauhan BC, Nicolela MT (2004) Factors associated with optic disc hemorrhages in glaucoma. Ophthalmology 111:1653–1657PubMedCrossRef
33.
Zurück zum Zitat Bengtsson B, Leske MC, Yang Z, Heijl A; EMGT Group (2008) Disc hemorrhages and treatment in the early manifest glaucoma trial. Ophthalmology 115:2044–2048CrossRef Bengtsson B, Leske MC, Yang Z, Heijl A; EMGT Group (2008) Disc hemorrhages and treatment in the early manifest glaucoma trial. Ophthalmology 115:2044–2048CrossRef
34.
Zurück zum Zitat Siegner SW, Netland PA (1996) Optic disc hemorrhages and progression of glaucoma. Ophthalmology 103:1014–1024PubMedCrossRef Siegner SW, Netland PA (1996) Optic disc hemorrhages and progression of glaucoma. Ophthalmology 103:1014–1024PubMedCrossRef
35.
Zurück zum Zitat De Moraes CG, Prata TS, Liebmann CA, Tello C, Ritch R, Liebmann JM (2009) Spatially consistent, localized visual field loss before and after disc hemorrhage. Invest Ophthalmol Vis Sci 50:4727–4733PubMedCrossRef De Moraes CG, Prata TS, Liebmann CA, Tello C, Ritch R, Liebmann JM (2009) Spatially consistent, localized visual field loss before and after disc hemorrhage. Invest Ophthalmol Vis Sci 50:4727–4733PubMedCrossRef
36.
Zurück zum Zitat Law SK, Choe R, Capriolo J (2001) Optic disk characteristics before the occurrence of disk hemorrhage in glaucoma patients. Am J Ophthalmol 132:411–413PubMedCrossRef Law SK, Choe R, Capriolo J (2001) Optic disk characteristics before the occurrence of disk hemorrhage in glaucoma patients. Am J Ophthalmol 132:411–413PubMedCrossRef
37.
Zurück zum Zitat Krakau CE (1983) Disc hemorrhages-forerunners of chronic glaucoma. In: Krieglstein GK, Leydhecker W (eds) Glaucoma update II. Gerlin, Springet-Verlag, pp 71–76CrossRef Krakau CE (1983) Disc hemorrhages-forerunners of chronic glaucoma. In: Krieglstein GK, Leydhecker W (eds) Glaucoma update II. Gerlin, Springet-Verlag, pp 71–76CrossRef
38.
Zurück zum Zitat Musch DC, Gillespite BW, Lichter PR et al (2009) Visual field progression in the Collaborative Initial Glaucma Treatment Study. The impact of treatment and other baseline factors. Ophthalmology 116:200–207PubMedCentralPubMedCrossRef Musch DC, Gillespite BW, Lichter PR et al (2009) Visual field progression in the Collaborative Initial Glaucma Treatment Study. The impact of treatment and other baseline factors. Ophthalmology 116:200–207PubMedCentralPubMedCrossRef
Metadaten
Titel
Results of long-term monitoring of normal-tension glaucoma patients receiving medical therapy: results of an 18-year follow-up
verfasst von
Shinya Komori
Kyoko Ishida
Tetsuya Yamamoto
Publikationsdatum
01.12.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 12/2014
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-014-2767-3

Weitere Artikel der Ausgabe 12/2014

Graefe's Archive for Clinical and Experimental Ophthalmology 12/2014 Zur Ausgabe

ACKNOWLEDGEMENT TO REFEREES

Thank you list 2014

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.